Shares of Moderna Inc. MRNA rose 4.33% to $154.81 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.56% to 13,192.34 and the Dow Jones Industrial Average DJIA falling 1.50% to 30,932.37. This was the stock's second consecutive day of gains. Moderna Inc. closed $34.45 short of its 52-week high ($189.26), which the company achieved on February 8th.
The stock outperformed some of its competitors Friday, as AbbVie Inc. ABBV rose 0.38% to $107.74, Amgen Inc. AMGN fell 1.14% to $224.92, and AstraZeneca PLC ADR AZN fell 1.08% to $48.38. Trading volume (13.3 M) remained 4.2 million below its 50-day average volume of 17.5 M.